Abdallah Kabbara, MD
Pain Medicine · Westlake, OHNPI 1275526428
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,500 of the $3,605 with a category attached, or 69.3%. Medtronic accounts for 83.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $2,581 and has fallen 94.2% since, to $150 in 2025.
Across 25 payments — averaging $144.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Indivior Inc.$142
- Comsort, Inc$100
- Nalu Medical, Inc.$69
- Averitas Pharma Inc.$59
- Curonix LLC$52
- plus $176 from 5 others
Across 101 payments — averaging $1729.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertos Medical, Inc.$170K
- Stryker$4K
- Medtronic$1K
What the payments were for
- Consulting fees$51314%
- Speaking & faculty fees$2,50069%
- Food & beverage$59116%
- Education$10%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 6 | $3,006 |
| Indivior Inc. | 3 | $142 |
| Comsort, Inc | 1 | $100 |
| Nalu Medical, Inc. | 3 | $69 |
| Averitas Pharma Inc. | 2 | $59 |
| Curonix LLC | 3 | $52 |
| Vertos Medical, Inc. | 1 | $48 |
| Boston Scientific | 1 | $43 |
| Relievant Medsystems, Inc. | 3 | $39 |
| Foundation Fusion Solutions, LLC | 1 | $28 |
| Painteq LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$2,500
- VECTRIS$413
- SUBLOCADE$123
- BRIDION$100
How this compares
$3,605 in reported general payments places this provider in the 60th percentile of 245 pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 402 | $6,157 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 31 | $5,307 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 182 | $3,725 |
| Fentanyl | 20 | $2,803 |
| Buprenorphine | 12 | $2,576 |
| Baclofen | 59 | $2,279 |
| Pregabalin | 105 | $1,852 |
| Methadone Hcl | 116 | $1,432 |
| Tramadol Hcl | 172 | $1,299 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $1,174 |
| Lidocaine | 17 | $1,069 |
| Oxycodone Hcl | 72 | $1,025 |
| Duloxetine Hcl | 48 | $875 |
| Tizanidine Hcl | 111 | $874 |
| Morphine Sulfate ErMorphine Sulfate | 38 | $845 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Westlake
- Alexander EscobarToledo$638K
- Nagy MekhailCleveland$511K
- Henry VuceticWilloughby$509K
- Tammy DannDayton$431K
- Michael DankoLoveland$381K
- Jonathan SilvermanDayton$234K
- Tristan WeaverColumbus$202K
- Robert BolashCleveland$154K
- Dmitri SouzaCuyahoga Falls$61K
- Aman UpadhyayCleveland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.